Alterations in behaviour, cerebral cortical morphology and cerebral oxidative stress markers following aspartame ingestion

Journal of Chemical Neuroanatomy

Volumn 78, Issue , 2016, Pages 42-56

  Onaolapo, Adejoke Y ^a,b   Onaolapo, Olakunle J ^a   Nwoha, Polycarp U ^b  

^a LADOKE AKINTOLA UNIVERSITY OF TECHNOLOGY   (Nigeria)

^b OBAFEMI AWOLOWO UNIVERSITY   (Nigeria)

Author keywords

Cerebral cortex; Glial fibrillary acid protein; Histology; Neuron specific enolase; Oxidative stress

Indexed keywords

ASPARTAME; ASPARTIC ACID; BIOCHEMICAL MARKER; GLIAL FIBRILLARY ACIDIC PROTEIN; NEURON SPECIFIC ENOLASE; NITRIC OXIDE; SUPEROXIDE DISMUTASE;

ACUTE DRUG ADMINISTRATION; ADULT; AMINO ACID BRAIN LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BEHAVIOR CHANGE; BRAIN CORTEX; BRAIN HISTOLOGY; CELL COUNT; CELL SIZE; CELL VACUOLE; CONTROLLED STUDY; DIETARY REFERENCE INTAKE; DRUG DOSE INCREASE; FLUID INTAKE; FOOD INTAKE; GLIA; GRANULE CELL; GROOMING; IMMUNOREACTIVITY; LOCOMOTION; MALE; MORPHOMETRICS; MOUSE; NERVE CELL LESION; NISSL SUBSTANCE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; REARING; REPEATED DRUG DOSE; SENILE PLAQUE; WEIGHT REDUCTION; ANIMAL; ANIMAL BEHAVIOR; BODY WEIGHT; DRUG EFFECTS; EATING; METABOLISM; MOTOR ACTIVITY; NERVE CELL; ORAL DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; ANIMALS; ASPARTAME; BEHAVIOR, ANIMAL; BODY WEIGHT; CEREBRAL CORTEX; EATING; GROOMING; MALE; MICE; MOTOR ACTIVITY; NEUROGLIA; NEURONS; NITRIC OXIDE; OXIDATIVE STRESS; SUPEROXIDE DISMUTASE;

EID: 84983550824     PISSN: 08910618     EISSN: 18736300     Source Type: Journal    
DOI: 10.1016/j.jchemneu.2016.08.006     Document Type: Article

References (131)

1. Abd El-Samad, A.A., Light and electron microscopic study on the effect of aspartame on the cerebellar cortex of male albino rat. Egypt J. Histol. 33:3 (2010), 419–430.
2. Abdel-Salam, O.M.E., Salem, N.A., El-Shamarka, M.E.S., Hussein, J.S., Ahmed, N.A.S., El-Nagar, M.E.S., Studies on the effects of aspartame on memory and oxidative stress in brain of mice. Eur. Rev. Med. Pharmacol. Sci. 16 (2012), 2092–2210.
3. Abhilash, M., Sauganth, M.V., Paul, M., Varghese, V., Harikumaran, R.N., Long-term consumption of aspartame and brain antioxidant defense status. Drug Chem. Toxicol. 36:2 (2013), 135–140.
4. Abu-Taweel, G.M., Zyadah, M.A., Ajarem, J.S., Ahmad, M., Cognitive and biochemical effects of monosodium glutamate and aspartame administered individually and in combination in male albino mice. Neurotoxicol. Teratol. 42 (2014), 60–67.
5. Abu-Taweel, G.M., Effect of monosodium glutamate and aspartame on behavioral and biochemical parameters of male albino mice. Afr. J. Biotechnol. 15:15 (2016), 601–612.
6. Ajayi, A.A., Ukponmwan, O.E., Evidence of angiotensin II and endogenous opioid modulation of novelty induced rearing in the rat. Afr. J. Med. Med. Sci. 23:3 (1994), 287–290.
7. Al-Khatib, I.M.H., Doè Kmeci, I., Fujiwara, M., Differential role of nucleus accumbens and caudate-putamen in mediating the effect of nomifensine and methamphetamine on ambulation and rearing of rats in the open-field test. Jpn. J. Pharmacol. 67:1 (1995), 69–77.
8. Anderson, G.H., Leiter, L.A., Effects of aspartame and phenylalanine on meal-time food intake of humans. Appetite(Suppl. 4), 1988, 8–53.
9. Anton, S.D., Martin, C.K., Han, H., Coulon, S., Cefalu, W.T., Geiselman, P., Effects of stevia, aspartame, and sucrose on food intake, satiety, and postprandial glucose and insulin levels. Appetite 55:1 (2010), 37–43.
10. Appleton, K.M., Blundell, J.E., Habitual high and low consumers of artificially-sweetened beverages: effects of sweet taste and energy on short term appetite. Physiol. Behav. 92:3 (2007), 479–486.
11. Ashok, I., Sheladevi, R., Biochemical responses and mitochondrial mediated activation of apoptosis on long-term effect of aspartame in rat brain. Redox Biol. 2 (2014), 820–831.
12. Ashok, I., Sheeladevi, R., Dapkupar, W., Acute effect of aspartame induced oxidative stress in Wistar albino rat brain. J. Biomed. Res., 28(0), 2014 000-000.
13. Ashwell, M., Gibson, S., de la Hunty, A., A review of the effectiveness of aspartame in helping with weight control. Br. Nutr. Bull. 31:2 (2006), 115–128.
14. Aspartame Information Centre, 2015. Online Aspartame Information Blogspot, http://www.aspartame.org (last assessed October 2015).
15. Associação Brasileira da Industria de Alimentos Dietéticos, 1994. Hábitos se atitude do consumidor de produtos dietéticos e de baixo teor de gordura. São Paulo.
16. Bachmanov, A.A., Reed, D.R., Tordoff, M.G., Price, R.A., Beauchamp, G.K., Nutrient preference and diet-induced adiposity in C57BL/6By J and 129P3/J mice. Physiol. Behav. 72 (2001), 603–613.
17. Ballinger, A.B., Clark, M.L., L-phenylalanine releases cholecystokinin (CCK) is associated with reduced food intake in humans. Evidence for physiological role of CCK in control of satiety. Metabolism 43 (1994), 735–738.
18. Barros, H.M., Tannhauser, S.L., Tannhauser, M.A., Tannhauser, M., The Effects of GABAergic drugs on grooming behaviour in the Open field. Pharmacol. Toxicol. 74:4-5 (1994), 339–344.
19. Beal, M.F., Hyman, B.T., Koroshetz, W., Do defects in mitochondrial energy metabolism underlie the pathology of neurodegenerative diseases?. Trends Neurosci. 16:4 (1993), 125–135.
20. Bellisle, F., Drewnowski, A., Intense sweeteners, energy intake and the control of body weight. Eur. J. Clin. Nutr. 61 (2007), 691–700.
21. Beninger, R.J., The role of dopamine in locomotor activity and learning. Brain Res. 287:2 (1983), 173–196.
22. Bergstrom, B.P., Cummings, D.R., Skaggs, T.A., Aspartame decreases evoked extracellular dopamine levels in the rat brain: an in-vivo voltammetry study. Neuropharmacology 53 (2007), 967–974.
23. Berridge, K.C., Aldridge, J.W., Super-stereotypy I: enhancement of a complex movement sequence by systemic dopamine D1 agonists. Synapse 37 (2000), 194–204.
24. Blaylock, R.L., Excitotoxins, Neurodegeneration and Neurodevelopment. 2000, Dorway http://dorway.com/doctors-speak-out/dr-blaylock/excitotoxins-.
25. Blum, J., Fridovich, I., Inactivation of glutathione peroxidase by superoxide dismutase radical. Arch. Biochem. Biophysiol. 240 (1985), 500–508.
26. Bowen, J., Evangelista, A.M., Brain Cell Damage from Amino Acid Isolates: A Primary Concern from Aspartame-based Products and Artificial Sweetening Agents. 2002, World Natural Health Organisation.
27. Burda, J.E., Sofroniew, M.V., Reactive gliosis and the multicellular response to CNS damage and disease. Neuron 81:2 (2014), 229–248, 10.1016/j.neuron.2013.12.034.
28. Burdock, G.A., Aspartame: In Fenaroli's Handbook of Flavour Ingredients. 5th ed., 2005, CRC Press, Boca Raton, FL, 118–119.
29. Burns, T.S., Stargel, W.W., Tsehanz, C., Kotdonis, F.N., Hurwitz, A., Aspartame and sucrose produce a similar increase in the plasma phenylalanine to large neutral amino acid ratio in healthy subjects. Pharmacology 43 (1991), 210–219.
30. Butchko, H.H., Stargel, W.W., Comer, C.P., Mayhew, D.A., Benninger, C., Blackburn, G.L., Intake of Aspartame vs. the acceptable daily intake. Reg. Tox. Pharmacol. 35 (2002), 13–16.
31. Christian, B., McConnaughey, K., Bethea, E., Brantle, S., Coffey, A., Hammond, L., Chronic aspartame affects-maze performance, brain cholinergic receptors and Na, K-ATPase in rats. Pharmacol. Biochem. Behav 78 (2004), 121–127.
32. Clemens, S., Belin-Rauscent, A., Simmers, J., Combes, D., Opposing modulatory effects of D1- and D2-like receptor activation on a spinal central pattern generator. J. Neurophysiol. 107 (2012), 2250–2259.
33. Coulombe, R.A., Sharma, R.S., Neurobiochemical alterations induced by the artificial sweetener aspartame (NutraSweet). Toxicol. Appl. Pharmacol. 83 (1986), 79–85.
34. Ding, M., Haglid, K.G., Hamberger, A., Quantitative immunochemistry on neuronal loss, reactive gliosis and blood brain barrier damage in cortex/striatum and hippocampus/amygdala after systemic kainic acid administration. Neurochem. Int. 36 (2000), 313–318.
35. Drewnowski, A., Massien, C., Louis-Sylvestre, J., Fricker, J., Chapelot, D., Apfelbaum, M., Comparing the effects of aspartame and sucrose on motivational ratings, taste preferences, and energy intakes in humans. Am. J. Clin. Nutr. 59:2 (1994), 338–345.
36. Dunn, A.J., Webster, E.L., Nemeroff, C.B., Neonatal treatment with monosodium glutamate does not alter grooming behavior induced by novelty or adrenocorticotropic hormone. Behav. Neural Biol. 44:1 (1985), 80–89.
37. EFSA, EFSA Assesses New Aspartame Study and Reconfirms Its Safety European Food Safety Authority. 2006, European Ramazzini Foundation, Bologna, Italy.
38. Eng, L., Ghirnikar, R., Lee, Y., Glial fibrillary acidic protein: GFAP-thirty-one years (1969–2000). Neurochem. Res. 251 (2000), 439–451.
39. FDA, Food additives permitted for direct addition to food for human: Aspartame. Food Drug Admin. Fed. Regist., 49, 1984, 6672.
40. FDA, Inactive Ingredients Database. Aspartame. US Food and Drug Administration. 2006, Center for Drug Evaluation and Research (CDER).
41. Feijó, F., Ballard, C.R., Foletto, K.C., Batista, B.A.M., Neves, A.M., Ribeiro, M.F.M., Bertoluci, M.C., Saccharin and aspartame, compared with sucrose, induce greater weight gain in adult Wistar rats, at similar total caloric intake levels. Appetite 60 (2013), 203–207.
42. Fernstorm, J.D., Fernstrom, M.H., Gillis, M.A., Acute effects of aspartame on large neutral amino acid and mono-amines in rat brain. Life Sci. 32 (1983), 1651–1658.
43. Finkelstein, M.W., Daabees, T.T., Stegink, L.D., Applebaum, A.E., Aspartate-induced neuronal necrosis in infant mice: protective effect of carbohydrate and insulin. J. Toxicol. Environ. Health 23 (1988), 395–406.
44. Finnerty, N., Saidhbhe, L.O., Klamer, D., Lowry, J., Pålsson, E., Increased brain nitric oxide levels following ethanol administration. Nitric 47 (2015), 52–57.
45. Fitzpatrick, C.A., The Effects of Caffeine and Aspartame on Food Intake and Anxiety in the Rat. 1994, Department of Psychology, Memorial University of Newfoundland.
46. Fountain, S.B., Hennes, S.K., Teyler, T.J., Aspartame exposure and in vitro hippocampal slice excitability and plasticity. Fundam. Appl. Toxicol. 11 (1988), 221–228.
47. Fowler, S.P., Williams, K., Resendez, R.G., Hunt, K.J., Hazuda, H.P., Stern, M.P., Fueling the obesity epidemic? Artificially sweetened beverage use and long-term weight gain. Obesity (Silver Spring) 16:8 (2008), 1894–1900.
48. Freeman, G., Sobotka, T., Hattan, D., Acute effects of aspartame on concentrations of brain amines and their metabolites in selected brain regions of Fischer 344 and Sprague-dawley rats. Drug Chem. Toxicol. 13 (1990), 113–133.
49. French food safety Agency (Agence Française De Sécurité Sanitaire Des Aliment), 2002. Maisons-Alfort. http://www.afssa.fr.
50. Goerss, A.L., Wagner, G.C., Hill, W.L., Acute effects of aspartame on aggression and neurochemistry of rats. Life Sci. 67 (2000), 1325–1329.
51. Hall, W.L., Millward, D.J., Roger, P.J., Morgan, L.M., Physiological mechanisms mediating aspartame induced satiety. Physiol. Behav. 78 (2003), 557–562.
52. Henry, B.L., Minassian, A., Young, J.W., Paulus, M.P., Geyer, M.A., Perry, W., Cross-species assessments of motor and exploratory behaviour related to bipolar disorder. Neurosci. Biobehav. Rev., 2010, 10.1016/j.neubiorev.2010.04.002.
53. Hooper, N.M., Hesp, R.J., Tieku, S., Metabolism of aspartame by human and pig intestinal microvillar peptidases. Biochem. J. 298 (1994), 635–639.
54. Humphries, P., Pretorius, E., Naudé, H., Direct and indirect cellular effects of aspartame on the brain. Eur. J. Clin. Nutr., 62, 2008, 451.
55. Iwanaga, T., Takahashi, Y., Fujita, T., Immunohistochemistry of neuron-specific and glia-specific proteins. Arch. Histol. Cytol. 52 (1989), 13–24.
56. Jacque, C.M., Vinner, C., Kujas, M., Raoul, M., Racadot, J., Baumann, N.A., Determination of glial fibrillary acidic protein (GFAP) in human brain tumors. J. Neurol. Sc. 35:1 (1978), 147–155.
57. Jeanningros, R., Vagal unitary responses to intestinal amino acid infusions in the anesthetized cat: a putative signal for protein-induced satiety. Physiol. Behav. 28 (1982), 9–21.
58. Kelley, A., Cador, M., Stinus, L., Exploration and its measurement: a psychopharmacological perspective. Boulton, G., (eds.) Neuromethods, 13: Psychopharmacology, 1989, Humana Press, Clifton, NJ, 95–144.
59. Komorowska, J., Pellis, S.M., Regulatory mechanisms underlying novelty-induced grooming in the Laboratory rat. Behav Process 67:2 (2004), 287–293.
60. Lambert, A.M., Bonkowsky, J.L., Masino, M.A., The conserved dopaminergic diencephalospinal tract mediates vertebrate locomotor development in zebrafish larvae. J. Neurosci. 32 (2012), 13488–13500.
61. Lavin, J.H., French, S.J., Read, N.W., The effect of sucrose- and aspartame sweetened drinks on energy intake, hunger and food choice of female, moderately restrained eaters. Int. J. Obesity Metab. Disorders 21:1 (1997), 37–42.
62. Lee, E.W., Garner, C.D., Terzo, T.S., Animal model for the study of methanol toxicity: comparison of folate-reduced rat responses with published monkey data. J. Toxicol. Environ. Health 41 (1994), 71–82.
63. Lindseth, G.N., Coolahan, S.E., Petros, T.V., Lindseth, P.D., Neurobehavioral effects of aspartame consumption. Res Nursing Health 37:3 (2014), 185–193.
64. Magnuson, B.A., Burdock, G.A., Doull, J., Kroes, R.M., Marsh, G.M., Pariza, M.W., Spencer, P.S., Waddell, W.J., Walker, R., Williams, G.M., Aspartame: a safety evaluation based on current use levels, regulations, and toxicological and epidemiological studies. Crit. Rev. Toxicol. 37 (2007), 629–727.
65. Maher, T.J., Wurtman, R.J., Possible neurologic effects of aspartame, a widely used food additive. Environ. Health Perspect. 75 (1987), 53–57.
66. Mattes, R., Popkin, B., Nonnutritive sweetener consumption in humans: effects on appetite and food intake and their putative mechanisms. Am. J. Clin. Nutr. 89 (2009), 1–14.
67. McCord, J.M., The evolution of free radicals and oxidative stress. Am. J. Med. 108 (2000), 65218–65222.
68. Miles, G.B., Sillar, K.T., Neuromodulation of vertebrate locomotor control networks. Physiology (Bethesda Md) 26 (2011), 393–411.
69. Mink, J.W., Thach, W.T., Basal ganglia intrinsic circuits and their role in behaviour. Curr. Opin. Neurobiol. 3 (1993), 950–957.
70. Moller, S.E., Effect of aspartame and protein administered in phenylalanine equivalence doses on plasma neutral amino acids, aspartate, insulin, and glucose in man. Pharmacol. Toxicol. 68 (1991), 408–412.
71. Montgomery, H.A.C., Dymock, J.F., The determination of nitrite in water. Analyst, 86, 1961, 414.
72. Mourad, I.M., Noor, N.A., Aspartame (a widely used artificial sweetener) and oxidative stress in the rat cerebral cortex. Int. J. Pharmacol. Biomed. Sci. 2 (2011), 4–10.
73. Mourad, M., Effect of aspartame on some oxidative stress parameters on liver and kidney of rats. Afr. J. Pharm. Pharmacol. 5:6 (2011), 672–678.
74. Moyaho, A., Valencia, J., Grooming and yawning trace adjustment to unfamiliar environments in laboratory Sprague-Dawley rats (Rattus norvegicus). J. Comp. Psychol. 116:3 (2002), 263–269.
75. Muller, M.B., Lucassen, P.J., Yassouridis, A., Hoogendijk, W.J., Holsboer, F., Swaab, D.F., Neither major depression nor glucocorticoid treatment affects the cellular integrity of the human hippocampus. Eur. J. Neurosci. 14 (2001), 1603–1612.
76. Muunrahainen, N.E., Kissileff, H.R., Dengatis, A.J., Pi-Sanyar, F.X., Effects of cholecystokinin-octapeptide (CCK-8) in food intake and gastric emptying in man. Physiol. Behav. 44 (1988), 645–649.
77. Nishikimi, M., Appaji, N., Yagi, K., The occurrence of superoxide anion in the reaction of reduced phenazine methosulfate and molecular oxygen. Biochem. Biophys. Res. Commum. 46 (1972), 849–854.
78. Nogami, M., Takatsu, A., Ishiyama, I., Immunohistochemical study of neuron specific enolase in human brains from forensic autopsies. For. Sci. Int. 94 (1998), 97–109.
79. Nosti-Palacios, R., Gomez-Garduno, J., Molina-Ortiz, D., Calzada-Leon, R., Dorado-Gonzalez, V.M., Vences-Mejia, A., Aspartame administration and insulin treatment altered brain levels of CYP2E1 and CYP3A2 in streptozotocin-induced diabetic rats. Int. J. Toxicol. 33:4 (2014), 325–331.
80. O'Callaghan, J.P., Sriram, K., Glial fibrillary acidic protein and related glial proteins as biomarkers of neurotoxicity. Expert Opin. Drug Saf. 4:3 (2005), 433–442.
81. Olney, J.W., Ho, O.L., Brain damage in infant mice following oral intake of glutamate, aspartate or cysteine. Nature 227 (1970), 609–611.
82. Olney, J.W., Farber, N.B., Spitznagel, E., Robins, L.N., Increasing brain tumour rates: Is there a link to aspartame?. J. Neuropath. Exp. Neurol. 55 (1996), 1115–1123.
83. Olney, J.W., Food additives: functional teratological aspects. Progress. Brain Res. 73 (1988), 283–294.
84. Omar, S.M.M., Effect of aspartame on the frontal cortex of adult male albino rats: A light and electron microscopic study. Egypt J. Histol. 32:2 (2009), 346–357.
85. Onaolapo, O.J., Onaolapo, A.Y., Acute low dose monosodium glutamate retards novelty induced behaviours in male Swiss albino mice. JNBH 3:4 (2011), 51–56.
86. Onaolapo, O.J., Onaolapo, A.Y., Sex differential effects of acute caffeine administration on open field novelty induced behaviour in Swiss albino mice. JNBH 3:8 (2011), 99–106.
87. Onaolapo, O.J., Onaolapo, A.Y., Akanmu, M.A., Olayiwola, G., Foraging enrichment modulates open field response to monosodium glutamate in mice. Annal. Neurosci. 22:3 (2015), 162–170.
88. Onaolapo, O.J., Onaolapo, A.Y., Akanmu, M.A., Olayiwola, G., Evidence of alterations in brain structure and antioxidant status following ‘low-dose’ monosodium glutamate ingestion. Pathophysiology, 2016, 10.1016/j.pathophys in press.
89. Parthasarathy, J.N., Ramasundaram, S.K., Sundaramahalingam, M., Rathinasamy, S.D., Methanol-induced oxidative stress in rat lymphoid organs. J. Occup. Health. 48 (2006), 20–27.
90. Patima, T., Neuronal cell markers. Mater. Methods, 3, 2013, 196.
91. Phelan, S., Lang, W., Jordan, D., Wing, R.R., Use of artificial sweeteners and fat-modified foods in weight loss maintainers and always-normal weight individuals. Int. J. Obesity (London) 33:10 (2009), 1183–1190.
92. Polyák, E., Gombos, K., Hajnal, B., Bonyár-Müller, K., Szabó, S., Gubicskó-Kisbenedek, A., Effects of artificial sweeteners on body weight, food and drink intake. Acta Physiol. Hungarica 97:4 (2010), 401–407.
93. Prakash, A., Jaspreet, K., Kalra, J.K., Kumar, A., Neuroprotective effect of N-acetyl cysteine against streptozocin-induced memory dysfunction and oxidative damage in rats. J. Basic Clin. Physiol. Pharmacol. 26:1 (2014), 6792–6855.
94. Puhl, J.G., Mesce, K.A., Dopamine activates the motor pattern for crawling in the medicinal leech. J. Neurosci. 28 (2008), 4192–4200.
95. Raben, A., Vasilaras, T.H., Møller, A.C., Astrup, A., Sucrose compared with artificial sweeteners. Different effects on ad-libitum food intake and body weight after 10 wk of supplementation in overweight subjects. Am. J. Clin. Nutr. 76:4 (2002), 21–29 7.
96. Rajasekar, P., Subramanian, P., Manivasagam, T., Circadian variations of biochemical variables in aspartame treated rats. Pharm. Biol. 42:1 (2004), 1–7.
97. Reilly, M.A., Debler, E.A., Fleischer, A., Lajtha, A.I, Chronic aspartame ingestion does not alter cerebral levels of aminergic neurotransmitters and related amino acids in the rat brain. Res. Commun. Psychol. Psych. Behav. 14 (1989), 287–303.
98. Reilly, M.A., Debler, E.A., Lajtha, A., Perinatal exposure to aspartame does not alter aminergic neurotransmitter systems in weanling rat brain. Res. Commun. Psychol. Psych. Behav. 15 (1990), 141–159.
99. Reynolds, W.A., Stegink, L.D., Filer Renn, L.J.E. Jr., Aspartame administration to the infant monkey: hypothalamic morphology and plasma amino acid levels. Anat. Rec. 198 (1980), 73–85.
100. Roessmann, U., Velasco, M.E., Sindely, S.D., Gambetti, P., Glial fibrillary acidic protein (GFAP) in ependymal cells during development An Immunocytochemical study. Brain Res., 2000(1), 1980 13-12.
101. Roger, P.J., Fleming, H.C., Blundell, J.E., Aspartame ingested without tasting inhibits hunger and food intake. Physiol. Behav. 47 (1990), 1239–1243.
102. Romano, M., Diomede, L., Guiso, G., Caccia, S., Perego, C., Salmona, M., Plasma and brain kinetics of large neutral amino acids and of striatum monoamines in rats given aspartame. Food Chem. Toxicol. 28 (1990), 317–321.
103. Rothman, S.M., Olney, J.W., Excitotoxicity and the NMDA receptor–still lethal after eight years. Trends Neurosci. 18:2 (1995), 57–58.
104. Rubinstein, M., Phillips, T.J., Bunzow, J.R., Falzone, T.L., Dziewczapolski, G., Zhang, G., Fang, Y., Larson, J.L., McDougal, J.A., Chester, J.A., Saez, C., Pugsley, T.A., Gershanik, O., Low, M.J., Grandy, D.K., Mice lacking dopamine D4 receptors are supersensitive to ethanol, cocaine, and methamphetamine. Cell 90 (1997), 991–1001.
105. Rycerz, K., Jaworska-Adamu, J.E., Effects of aspartame metabolites on astrocytes and neurons. Folia Neuropathol. 51:1 (2013), 10–17.
106. Shapiro, R.B., Statement for the labour and human resources committee. US Senate. 1988, Government Printing Office, Washington, DC.
107. Sharma, R.P., Coulombe, R.A. Jr., Effects of repeated doses of aspartame on serotonin and its metabolite in various regions of the mouse brain. Food Chem. Toxicol. 25:8 (1987), 565–568.
108. Simintzi, I., Schulpis, K.H., Angelogianni, P., Liapi, C., Tsakiris, S., The effect of aspartame on acetylcholinesterase activity in hippocampal homogenates of suckling rats. Pharmacol. Res. 56:2 (2007), 155–159.
109. Smith, B.K., Andrews, P.K., West, D.B., Macronutrient diet selection in thirteen mouse strains. Am. J. Physiol. Regul. Integ. Comp. Physiol 278 (2001), R797–805.
110. Soffritti, M., Belpoggi, F., Degli Esposti, D., Lambertini, L., Tibaldi, E., Rigano, A., First experimental demonstration of the multipotential carcinogenic effects of aspartame administered in the feed to Sprague-Dawley rats. Environ. Health Perspect. 114:3 (2006), 379–385.
111. Sofroniew, M.V., Vinters, H.V., Astrocytes: biology and pathology. Acta Neuropathol. 119:1 (2010), 7–35, 10.1007/s00401-009-0619-8.
112. Sofroniew, M.V., Reactive astrocytes in neural repair and protection. Neuroscientist 11:5 (2005), 400–407.
113. Spruijt, B.M., van Hooff, J.A., Gispen, W.H., Ethology and neurobiology of grooming behaviour. Physiol. Rev. 72:2 (1992), 825–852.
114. Stegink, L.D., Filer, L.J. Jr., Baker, G.L., Effect of aspartame and aspartate loading upon plasma and erythrocyte free amino acid levels in normal adult volunteers. J. Nutr. 107 (1977), 1837–1845.
115. Stegink, L.D., Filer, L.J. Jr., Baker, G.L., Plasma and erythrocyte concentrations of free amino acids in adult humans administered abuse doses of aspartame. J. Toxicol. Environ. Health 7 (1981), 291–305.
116. Stegink, L.D., Filer, L.J., Bell, E.F., Ziegler, E.E., Tephly, T.R., Effect of repeated ingestion of aspartame-sweetened beverage on plasma amino acid, blood methanol, and blood formate concentrations. Metabolism 34:4 (1989), 357–363.
117. Stegink, L.D., The aspartame story: a model for the clinical testing of a food additive. Am. J. Clin. Nutr. 46 (1987), 204–215.
118. Steinert, J.R., Chernova, T., Forsythe, I.D., Nitric oxide signaling in brain function, dysfunction and dementia. Neuroscientist 16:4 (2010), 435–452.
119. Stone, T.W., Burton, N.R., NMDA receptors and ligands in the vertebrate. CNS Prog. Neurobiol. 30 (1988), 333–368.
120. Svensson, J., Carlsson, A., Huff, R.M., Kling-Petersen, T., Waters, N., Behavioural and neurochemical data suggest functional differences between dopamine D2 and D3 receptors. Eur. J. Pharmacol. 263 (1994), 235–243.
121. Svensson, E., Woolley, J., Wikström, M.A., Grillner, S., Endogenous dopaminergic modulation of the lamprey spinal locomotor network. Brain Res. 970 (2003), 1–8.
122. Swithers, S.E., Davidson, T.L., A role for sweet taste Calorie predictive relations in energy regulation by rats. Behav. Neurosci. 122:1 (2008), 161–173.
123. Torii, K., Mimura, T., Takasaki, Y., Ichimura, M., Dietary aspartame with protein on plasma and brain amino acids, brain monoamines and behavior in rats. Physiol. Behav. 36 (1986), 765–771.
124. Trocho, C., Pardo, R., Rafecas, I., Virgili, J., Remesar, X., Fernández López, J.A., Alemany, M., Formaldehyde derived from dietary aspartame binds to tissue components in vivo. Life Sci. 63:5 (1998), 337–349.
125. Van Wymelbeke, V., Béridot-Thérond, M.E., de La Guéronnière, V., Fantino, M., Influence of repeated consumption of beverages containing sucrose or intense sweeteners on food intake. Eur. J. Clin. Nutr. 58:1 (2004), 154–161.
126. Wallin, A., Blennow, K., Rosengren, L., Cerebrospinal fluid markers of pathogenetic processes in vascular dementia, with special reference to the subcortical subtype. Alzheimer Dis. Assoc. Disord. 13 (1999), S102–7.
127. Wilhelmsson, U., Bushong, E.R., Price, D.L., Smarr, B.L., Phung, V., Terada, M., Ellisman, M.H., Pekny, M., Redefining the concept of reactive astrocytes as cells that remain within their unique domains upon reaction to injury. Proc. Natl. Acad. Sci. U. S. A. 103:46 (2006), 17513–17518, 10.1073/pnas.0602841103 14.
128. Wurtman, R.J., Neurochemical changes following high-dose aspartame with dietary carbohydrate. N. Engl. J. Med. 309 (1983), 429–430.
129. Xu, M., Moratalla, R., Gold, L.H., Hiroi, N., Koob, G.F., Graybiel, A.M., Tonegawa, S., Dopamine D1 receptor mutant mice are deficient in striatal expression of dynorphin and in dopamine-mediated behavioral responses. Cell 79 (1994), 729–742.
130. Yang, Q., Gain weight by “going diet?” Artificial sweeteners and the neurobiology of sugar cravings. Neurosci. Yale J. Biol. Med. 83:2 (2010), 101–108.
131. Yokogoshi, H., Wurtman, R.J., Acute effects of oral or parenteral aspartame on catecholamine metabolism in various regions of rat brain. J. Nutr. 116 (1986), 356–364.